Divi's Laboratories Ltd. reported its earnings for the September quarter, delivering a strong performance that surpassed estimates on all fronts and showed improvement across...
Shares of Pharma companies, Divi's Laboratories, Syngene, Laurus Labs, Piramal Pharma, and Blue Jet Healthcare, surged up to 5% on Friday, October 10, after...
Brokerage firm Jefferies has initiated coverage on Cohance Lifesciences with a "buy" recommendation on Monday, August 25. The stock gained over 1% in response.Jefferies...
Divi's Laboratories Ltd. reported a 14% year-on-year growth in revenue at ₹2,410 crore, compared to ₹2,118 crore in the year-ago quarter. However, the figure...